Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
Follow TEM
Alert me
Tempus AI, Inc. (TEM) Free cash flow margin
Tempus AI, Inc.'s free cash flow margin over the twelve months to 30 September 2026 was −9.98%, up 9.3 percentage points from fiscal 2025 (−19.3%). That is below the Health Information Services industry median of 0.00% and below the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | −19.3% | 11.16 |
| FY2024 | −30.5% | 16.36 |
| FY2023 | −46.8% | 11.38 |
| FY2022 | −58.2% | — |
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| VEEV Veeva Systems Inc. compare | 47.4% |
| DOCS Doximity, Inc. compare | 46.2% |
| HNGE Hinge Health Inc. compare | 39.4% |
| HQY HealthEquity, Inc. compare | 32.1% |
| WAY Waystar Holding Corp. compare | 20.9% |
| PRVA Privia Health Group, Inc. compare | 4.44% |
| BTSG BrightSpring Health Services, Inc. compare | 3.23% |
| TEM Tempus AI, Inc. | −9.98% |
| HTFL Heartflow, Inc. compare | −27.9% |
| Health Information Services industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on TEM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement